Pharmaceutical Market Europe • January 2024 • 3

COMMENT

2024: the year of collaboration and partnership

Happy New Year and welcome to the January issue of PME. In this issue, we look at a number of different areas, from improving patient outcomes and the need for better mental health care to the benefits of precision medicine.

In his interview on page 28, Danny Buckland talks to Ed Piper, Medical & Scientific Affairs Director at AstraZeneca UK, about how the company is working to improve patient outcomes. As healthcare organisations face huge societal challenges, 2024 will be a year where the focus is on collaboration and partnership to drive mutual benefit, underpinning a growing structure of collaborations designed to destress healthcare systems and identify new, leaner ways of working.

In our second interview in this issue, Joanne Kanaan, CEO and Co-Founder of Omini, talks about the potential role of precision medicine in chronic diseases and the challenges patients face in managing their conditions. As Joanne says: “It is estimated that six out of ten people over the age of 60 suffers from at least one chronic condition, and four out of ten suffer from two or more. In England particularly, approximately 15 million people have a long-term condition.” Read more on page 16.

In the article on page 18 by Tamara Werner-Kiechle, Therapeutic Area Lead for Neuroscience and Pulmonary Hypertension at Janssen EMEA, she focuses on the need for better care for those struggling with their mental health, saying that “40 million people in the European Union (EU) alone live with depression, yet three out of four say they don’t receive adequate treatment for this” and that “it’s time for policymakers, healthcare systems and society to do more and start taking action”.

Looking ahead, our February issue will focus on diversity and inclusion in the pharma industry – how much has changed and how much more work is there to be done? If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Deputy Editor
Emily Kimber

Journalist/Editorial Assistant
Jen Brogan


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2024 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image